The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.5b00733

Source: Molecular Pharmaceutics - January 19, 2016 Category: Drugs & Pharmacology Authors: Shingen Misaka, Jana Knop, Katrin Singer, Eva Hoier, Markus Keiser, Fabian Müller, Hartmut Glaeser, Jörg König and Martin F. Fromm Source Type: research